Xiangxue Pharmaceutical Co.,Ltd. (300147.SZ)
CNY 12.14
(2.53%)
CNY 12.14
(2.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.29 Billion | 2.18 Billion | 2.97 Billion | 3.07 Billion | 2.78 Billion | 2.5 Billion |
| Cost of Revenue | 1.55 Billion | 1.64 Billion | 2.19 Billion | 2.07 Billion | 1.9 Billion | 1.59 Billion |
| Gross Profit | 743.33 Million | 542.51 Million | 779.28 Million | 992.56 Million | 880.8 Million | 913.14 Million |
| Operating Expenses | 1.12 Billion | 688.85 Million | 734.18 Million | 628.27 Million | 664.33 Million | 619.51 Million |
| Selling, General and Administrative Expenses | 400.93 Million | 421.24 Million | 487.58 Million | 430.39 Million | 458.89 Million | 439.79 Million |
| Research and Development Expenses | 89.75 Million | 94.79 Million | 90.6 Million | 66.98 Million | 61.26 Million | 38.67 Million |
| Other Expenses | 744.79 Million | 172.82 Million | 156 Million | 130.89 Million | 144.17 Million | -14.02 Million |
| Cost and Expenses | 2.63 Billion | 2.33 Billion | 2.92 Billion | 2.7 Billion | 2.56 Billion | 2.21 Billion |
| Operating Income | 53.79 Million | -152.93 Million | 34.98 Million | 327.97 Million | 275.21 Million | 126.02 Million |
| Interest Expense | 237.05 Million | 213.2 Million | 202.05 Million | 130.29 Million | 150.68 Million | 145.68 Million |
| Income Tax Expense | 12.79 Million | -6.79 Million | 22.92 Million | 24.34 Million | -9.05 Million | 24.03 Million |
| Earnings before Tax | -388.95 Million | -514.71 Million | -635.77 Million | 166.13 Million | 117.07 Million | 112 Million |
| Net Income | -388.96 Million | -507.92 Million | -658.69 Million | 141.79 Million | 126.12 Million | 56.43 Million |
| Earnings Per Share Basic | -0.59 | -0.77 | -1.00 | 0.22 | 0.19 | 0.09 |
| Earnings Per Share Diluted | -0.59 | -0.77 | -1.00 | 0.22 | 0.19 | 0.09 |
| Weighted Average Shares Outstanding | 659.26 Million | 658.71 Million | 658.71 Million | 655.3 Million | 652.7 Million | 627.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 659.26 Million | 658.71 Million | 658.71 Million | 655.3 Million | 652.7 Million | 627.1 Million |
| Gross Margin | 0.32 | 0.25 | 0.26 | 0.32 | 0.32 | 0.36 |
| EBIT Margin | 0.07 | 0.04 | 0.06 | 0.15 | 0.14 | 0.18 |
| Profit Margin | -0.17 | -0.23 | -0.22 | 0.05 | 0.05 | 0.02 |
| EBITDA | 151.21 Million | 89.36 Million | -238.11 Million | 319.62 Million | 412.42 Million | 370.33 Million |
| Earnings Before Tax Margin | 0.02 | -0.07 | 0.01 | 0.11 | 0.10 | 0.05 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 437.01 Million | 527.68 Million | 568.85 Million | 2.29 Billion | 571.1 Million | 526.82 Million |
| Cost of Revenue | 322.49 Million | 369.08 Million | 365.04 Million | 1.5 Billion | 405.61 Million | 350.28 Million |
| Gross Profit | 114.52 Million | 158.59 Million | 203.8 Million | 789.76 Million | 165.49 Million | 176.54 Million |
| Operating Expenses | 146.61 Million | 121.57 Million | 165.58 Million | 652.74 Million | 166.58 Million | 168.49 Million |
| Selling, General and Administrative Expenses | 273.28 Million | 42.43 Million | 149.97 Million | - | -51.73 Million | 257.46 Million |
| Research and Development Expenses | 17.7 Million | 18.02 Million | 17.32 Million | - | 44.95 Million | 15.75 Million |
| Other Expenses | -144.37 Million | -21.82 Million | -9.65 Million | -56.23 Million | -28.39 Million | -10.27 Million |
| Cost and Expenses | 469.1 Million | 490.65 Million | 530.63 Million | 2.16 Billion | 572.19 Million | 518.77 Million |
| Operating Income | -72.05 Million | -67.55 Million | -16.67 Million | -332.71 Million | -233.18 Million | -58.82 Million |
| Interest Expense | 67.94 Million | 58.21 Million | 51.71 Million | 237.05 Million | 58.38 Million | 55.53 Million |
| Income Tax Expense | 3.87 Million | 2.87 Million | 2.29 Million | 12.79 Million | 8.27 Million | 4.38 Million |
| Earnings before Tax | -72.13 Million | -89.37 Million | -26.33 Million | -388.95 Million | -261.57 Million | -69.11 Million |
| Net Income | -82.57 Million | -99.56 Million | -35.65 Million | -388.96 Million | -242.89 Million | -80.07 Million |
| Earnings Per Share Basic | -0.13 | -0.15 | -0.05 | - | -0.38 | -0.12 |
| Earnings Per Share Diluted | -0.13 | -0.15 | -0.05 | - | -0.38 | -0.12 |
| Weighted Average Shares Outstanding | 658.71 Million | 658.71 Million | 713.19 Million | 659.26 Million | 645.14 Million | 658.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 658.71 Million | 658.71 Million | 713.19 Million | 659.26 Million | 645.13 Million | 658.71 Million |
| Gross Margin | 0.26 | 0.30 | 0.36 | 0.34 | 0.29 | 0.34 |
| EBIT Margin | -0.01 | 0.02 | 0.05 | - | -0.14 | -0.01 |
| Profit Margin | -0.19 | -0.19 | -0.06 | -0.17 | -0.43 | -0.15 |
| EBITDA | -4.18 Million | 9.9 Million | 26.98 Million | - | -78.42 Million | -6.03 Million |
| Earnings Before Tax Margin | -0.16 | -0.13 | -0.03 | -0.14 | -0.41 | -0.11 |
SAABY
603076
GWO-PI
EDTXF
SPOK
FULT